Conference abstractPublished 12 Nov 2013
The application of quality by design principles to analytical methods
Abstract
Select any words in the title or abstract, or press this and choose a sentence.
Following the implementation of ICH Q8, Q9 and Q10 for drug product development and manufacture, a number of major pharmaceutical companies developed an interest in extending Quality by Design to analytical methods. The analytical target profile (ATP) concept was developed by industry as a mechanism for enabling method flexibility, with the vision that any methods complying with the ATP could be interchanged without regulatory approval. However, the implications of the ATP on method performance requirements were not fully developed/understood/articulated. Examples of the implications of ATP requirements for chromatographic method development and subsequent routine use will be given and the pros and cons of developing analytical methods, within a Quality by Design framework, will be discussed. Discussion of the regulatory acceptability of the ATP concept in its entirety (leading to method flexibility) and whether analytical Quality by Design should be placed in the regulatory environment or whether industry?s needs are best served via ICH Q2, will take place
Subjects
Pharmaceutical SciencesAsk about this article
Answers come only from this article's title, abstract and keywords, each sentence pointing to where it comes from. Your question is sent to OpenAI to write the answer. Scholars Central does not store it.
Follow
New articles from what you follow go into your email digest, once you agree to alert emails.
- JournalJournal of Developing Drugs
- SubjectPharmaceutical Sciences
- BylineArticles whose byline prints “Peter Jones”

